Nawaloka Hospital
A Sri Lankan private hospital group providing tertiary, specialist, diagnostic, emergency, and outpatient healthcare services.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Nawaloka Hospital is a Sri Lankan private healthcare brand and hospital group founded in 1985 by businessman H. K. Dharmadasa. It was established as Sri Lanka’s first corporate private hospital and developed into one of the country’s largest private hospital networks. The organization operates under the Nawaloka Hospital Group and is associated with Nawaloka Hospitals PLC, which was listed on the Colombo Stock Exchange in 2004. The hospital’s development has been closely linked to the modernization of private medical care in Sri Lanka. Nawaloka introduced several forms of advanced hospital infrastructure and specialist treatment to the country, including intensive care, coronary care, laparoscopic surgery, and thoracic surgery. In 1987, it introduced CT and MRI scanning in Sri Lanka, expanding the role of private hospitals in advanced diagnosis. The group has also been credited with establishing specialized critical-care capacity through intensive care units serving medical, surgical, and cardiac patients. Nawaloka’s principal facility is a large multispecialty hospital in Colombo with more than 400 beds and a workforce reported at over 1,000 employees. Its clinical model combines inpatient treatment, outpatient consultations, emergency medicine, surgery, diagnostic imaging, laboratory medicine, pharmacy services, rehabilitation, and specialist clinics. The group also controls a network of approximately ten Nawaloka medical centres across Sri Lanka, extending access beyond its main hospital campus. The brand’s services include emergency treatment, intensive and coronary care, surgical theatres, dialysis, cardiology and catheterization-laboratory services, neurology, neurosurgery support, urology, rheumatology, dermatology, fertility and reproductive health, ophthalmology and LASIK, dentistry, oncology, neonatal care, physiotherapy, audiology, and ear, nose and throat care. Diagnostic capabilities include laboratory testing, X-ray, ultrasound, CT, MRI, mammography, bone-density testing, Holter monitoring, electrocardiography, echocardiography, sleep studies, urine-flow measurement, and electroencephalography. Quality management has been an important part of Nawaloka’s institutional positioning. The hospital won Sri Lanka’s first Sri Lanka Quality Award in 1998 and received ISO 9001:2008 certification in 2011. Later references identify ISO 9001:2015 certification and additional business, food-hygiene, and management recognitions. These distinctions support the group’s positioning as a structured, technology-oriented private provider rather than a single-service clinic. More recently, Nawaloka has emphasized diagnostic technology and digital healthcare innovation. It launched SARS-CoV-2 PCR testing after receiving approval from the Sri Lankan government and has promoted artificial-intelligence-assisted radiology. Its materials describe an AI-enabled MRI and a radiology centre launched in 2024, using deep-learning tools to improve image quality, scanning efficiency, and the identification of abnormalities across neurological, musculoskeletal, cardiovascular, abdominal, and oncological imaging. The stated role of these systems is to support clinicians rather than replace medical judgment. Nawaloka’s present brand proposition is built around broad tertiary-care capability, specialist access, advanced diagnostics, emergency readiness, and a national medical-centre network. Its primary market is Sri Lanka, with the Colombo hospital serving as the group’s central high-acuity and multispecialty institution.
History
Nawaloka Hospital was founded in 1985 by Sri Lankan businessman H. K. Dharmadasa, also known as Nawaloka Mudalai. Its creation marked the emergence of the first corporate private hospital in Sri Lanka, at a time when advanced hospital services were primarily associated with the public sector. From its Colombo base, Nawaloka developed a broad multispecialty model combining medical consultations, inpatient care, surgery, diagnostics, emergency treatment, and specialist services. During its early development, Nawaloka helped introduce infrastructure that was relatively new to Sri Lankan private healthcare. The hospital became associated with intensive care units, coronary care units, laparoscopic surgery, and thoracic surgery. In 1987, it introduced CT and MRI scanning in Sri Lanka, strengthening the role of private hospitals in complex diagnosis and supporting the growth of specialist medicine. The organization expanded from a single hospital into a wider hospital group. Its main facility grew to more than 400 beds and more than 1,000 staff members, while a network of approximately ten Nawaloka medical centres extended the brand’s presence across the island. This network allowed the group to provide both centralized tertiary care and more geographically distributed outpatient and diagnostic services. Nawaloka’s institutional development also included formal quality and corporate milestones. It received Sri Lanka’s first Sri Lanka Quality Award in 1998. The hospital group was listed on the Colombo Stock Exchange in 2004, creating a public-company structure for the healthcare business. In 2011, it received ISO 9001:2008 certification; later references identify ISO 9001:2015 certification as part of its quality-management credentials. The group’s service portfolio broadened over time. In addition to general inpatient and outpatient treatment, it developed critical-care units, operating theatres, dialysis, pharmacy operations, laboratory medicine, radiology, cardiac diagnostics and intervention, oncology support, fertility services, neonatal care, ophthalmology, dental care, rehabilitation, audiology, and home nursing. The hospital also operates emergency treatment and ambulance functions and provides specialist access through channeling and appointment services. During the COVID-19 period, Nawaloka introduced SARS-CoV-2 PCR testing after receiving approval from the Sri Lankan government. This extended its diagnostic role into infectious-disease testing and public-health response. In the 2020s, the organization emphasized artificial intelligence and advanced imaging. Nawaloka described the introduction of an AI-powered radiology centre in 2024, including an AI-driven MRI system using deep-learning techniques to improve image clarity, shorten examination times, and assist with the detection of abnormalities. The stated applications span neurological, musculoskeletal, cardiovascular, abdominal, and oncological imaging. The technology is presented as clinical decision support intended to augment radiologists and other physicians. Nawaloka Hospital remains an active Sri Lankan private hospital brand. Its identity is based on national healthcare infrastructure, broad tertiary-care provision, specialist access, diagnostic technology, formal quality systems, and a combination of hospital and medical-centre locations.
- 2024
AI-powered radiology centre
[2]Nawaloka promoted the launch of an AI-powered radiology centre and AI-assisted MRI capability.
- 2011
ISO 9001:2008 certification
[1]The hospital received ISO 9001:2008 certification.
- 2004
Stock-exchange listing
[1]Nawaloka Hospital Group was listed on the Colombo Stock Exchange.
- 1998
Sri Lanka Quality Award
[1]Nawaloka Hospital won Sri Lanka’s first Sri Lanka Quality Award.
- 1987
CT and MRI introduced
[1]Nawaloka introduced CT and MRI scanning in Sri Lanka.
- 1985
Hospital founded
[1]H. K. Dharmadasa founded Nawaloka Hospital as Sri Lanka’s first corporate private hospital.
Products and positioning
A large, technology-oriented Sri Lankan private hospital group positioned around comprehensive tertiary care, specialist treatment, advanced diagnostics, emergency services, and patient-centred healthcare.
Hospital services · 1985
Multispecialty tertiary hospital care
Nawaloka’s core offering combines inpatient admission, outpatient consultations, emergency treatment, surgery, intensive care, specialist clinics, pharmacy support, and discharge or follow-up services. The model is designed to handle routine consultations as well as complex cases requiring multidisciplinary treatment and prolonged hospitalization.
Critical care
Critical care services
The hospital operates intensive and coronary care capabilities, including medical, surgical, cardiac, and other high-dependency units. These services provide continuous monitoring and life-support capacity for seriously ill patients, including those requiring postoperative, cardiac, or emergency management.
Diagnostics · 1987
Diagnostic imaging and laboratory services
Nawaloka provides laboratory testing and a broad imaging portfolio that includes X-ray, ultrasound, CT, MRI, mammography, bone-density scanning, echocardiography, ECG, Holter monitoring, sleep studies, and EEG. These services support screening, diagnosis, treatment planning, and monitoring across multiple specialties.
Specialist medicine
Cardiology and cath-lab services
The cardiology offering includes cardiac assessment, electrocardiographic and echocardiographic testing, monitoring, and procedures supported by a catheterization laboratory. It forms part of the group’s wider cardiac-care and coronary-care capabilities.
Digital diagnostics · 2024
AI-assisted radiology
Nawaloka’s AI-assisted radiology initiative integrates deep-learning tools into medical imaging workflows. The promoted applications include AI-supported MRI intended to improve image clarity, processing speed, and the identification of abnormalities while leaving clinical interpretation and decisions with medical professionals.
Outpatient network
Nawaloka Medical Centres
The group operates a network of approximately ten Nawaloka medical centres across Sri Lanka. These locations extend outpatient consultations, specialist channeling, diagnostics, pharmacy access, and related services beyond the main Colombo hospital.
Brand decisions
2024
Launch AI-powered radiology capabilityProduct launchBackground
Nawaloka sought to improve the speed and precision of diagnostic imaging through artificial intelligence and deep-learning tools.
Action taken
The group launched or promoted an AI-powered radiology centre and AI-assisted MRI services.
Aftermath
The initiative strengthened Nawaloka’s positioning around advanced diagnostic technology and clinical decision support.
2004
List the hospital group on the Colombo Stock ExchangeStrategyBackground
The hospital group had expanded beyond a single facility and required a formal corporate structure for its continuing development.
Action taken
Nawaloka Hospital Group became listed on the Colombo Stock Exchange.
Aftermath
The listing established Nawaloka Hospitals PLC as a publicly traded healthcare company.
1987
Introduce CT and MRI scanningProduct launchBackground
The hospital sought to expand advanced diagnostic capability in Sri Lanka’s private healthcare sector.
Action taken
Nawaloka introduced CT and MRI scanning services.
Aftermath
The initiative became one of the hospital’s notable contributions to the development of advanced private medical diagnostics in Sri Lanka.
Recent events
- 2024
Nawaloka promotes AI-assisted radiology and MRI[2]
Product launch · Other
Nawaloka launched an AI-powered radiology centre and promoted deep-learning-supported MRI technology for faster imaging and enhanced diagnostic interpretation.
- 2004
Nawaloka Hospital Group listed on the Colombo Stock Exchange[1]
Other
Nawaloka Hospital Group, associated with Nawaloka Hospitals PLC, became a listed company on the Colombo Stock Exchange.
Nawaloka launches SARS-CoV-2 PCR testing[2]
Product launch · Regulation
The hospital group introduced SARS-CoV-2 PCR testing following approval from the Sri Lankan government.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nawaloka-hospital · Editorial policy · How profiles are compiled